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The interaction of simian foamy viruses (FVs) with their putative cellular receptor(s) was studied with two types of
recombinant envelope protein (Env). Transient expression of full-length Env in BHK-21 cells induced syncytia formation.
However, selected stable transfectants fused with naive cells but not with each other. A soluble fusion protein of the Env
surface domain with the Fc fragment of a human IgG1 heavy chain (EnvSU–Ig) was produced in the baculovirus expression
system, purified to homogeneity, and used for binding and competition analyses. EnvSU–Ig but not unrelated Ig fusion
proteins bound to cells specifically. Neutralizing serum blocked binding of EnvSU–Ig and, vice versa, serum-mediated
neutralization was abrogated by the chimeric protein. Concomitant reduction of EnvSU–Ig binding and FV susceptibility was
seen in Env-expressing target cells. Although EnvSU–Ig did not inhibit FV infection, very likely due to its displacement by
multivalent virus–cell interactions, this divalent ligand should help to characterize functionally and to identify the ubiquitous
FV receptor. © 1999 Academic Press
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Foamy viruses (FVs) are complex retroviruses that
ccur in some mammalian species (Hooks and Gibbs,
975; Loh, 1993; Neumann-Haefelin et al., 1993). A so-
alled human FV (HFV; Achong et al., 1971; Flu¨gel et al.,
987; Maurer et al., 1988) probably represents a chim-
anzee FV variant (SFVcpz; Herchenro¨der et al., 1994,
995).
FVs encode the structural genes gag, pol, and env and
wo regulatory genes (Rethwilm, 1995). Retrovirus env
enes encode a glycoprotein precursor. Env processing
ncludes oligosaccharide modifications and proteolytic
leavage to yield the viral surface (SU) and transmem-
rane (TM) domains (Hunter and Swanstrom, 1990). Gen-
rally, SU mediates receptor binding and determines the
irus host range and tissue specificity (Coffin, 1996).
resumably, also the FV Env proteins fulfill these func-
ions. Expression of retroviral Env interferes with (super)-
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228nfection by viruses of the same interference group via
eceptor down-regulation (Stevenson et al., 1988; Hoxie
t al., 1986) or shedding of SU (Schneider et al., 1986)
nd subsequent interference from without (Hunsmann et
l., 1974).
In contrast to other retroviruses, FV TM harbors an
ndoplasmatic reticulum (ER) retrieval signal, which re-
ains a major proportion of Env in the ER, and may,
hereby, facilitate intracellular virus budding (Goepfert et
l., 1997). Unlike other retroviruses, FVs exhibit an ex-
eptionally wide host range by productively infecting all
ammalian (Mikovits et al., 1996; Yu et al., 1996; Mergia
t al., 1997) as well as avian (Russell and Miller, 1996)
ell lines examined so far. Elucidation of the FV cell
inding mechanisms is essential to understanding this
road host range. Since FV-resistant cells as major pre-
equisites toward genetic methods for receptor identifi-
ation have not been described so far, we applied a
rotein-dependent approach to study the FV SU receptor
nteractions.
RESULTS AND DISCUSSION
xpression and purification of FV EnvSU as a
ecombinant soluble and divalent chimeric protein
To study binding of the FV surface glycoprotein to
arget cells, we constructed a recombinant chimeric fu-
ion protein termed EnvSU–Ig. The transfer vector for
aculovirus expression of EnvSU–Ig contained the
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229BINDING OF FOAMY VIRUS ENVELOPE PROTEIN TO HOST CELLSFVcpz envelope SU domain including the native signal
equence at the N-terminus. A truncated human IgG
lass 1 constant region facilitated EnvSU–Ig isolation
nd detection in binding and functional assays (Fig. 1A).
The DNA construct was used to produce recombinant
V. Infection of Sf 158 cells with this BV stock led to
ecretion of EnvSU–Ig, which was analyzed by SDS–
AGE and immunoblotting. A one-step purification pro-
edure for EnvSU–Ig via protein-A–Sepharose (Moos-
ayer et al., 1994a,b) yielded a virtually homogenous
FIG. 1. Production and purification of EnvSU–Ig. (A) The EnvSU–Ig exp
re indicated by arrows. The amplimer was cloned and subsequently
onstant region. The construct was used to generate recombinant BV
nd purification of EnvSU–Ig expressed in insect cells. BV recombinant
f 158 were also infected with BV expressing an irrelevant protein (lane
and 5) were analyzed by SDS–PAGE under nonreducing (lanes 1, 3–5)
ith anti-human IgG (lanes 1–4). To determine homogeneity of the reco
tained (lane 5).reparation and preserved the size of the homodimeric tolecule (Fig. 1B, lanes 4 and 5). By comparison with a
ommercial human IgG standard, the production yield of
nvSU–Ig ranged between 1 and 2 mg of purified protein
er liter of supernatant from infected Sf 158 cells. In
onreducing silver-stained SDS–PAGE gels EnvSU–Ig
igrated at a position corresponding to 210 kDa and its
dentity was confirmed by immunoblot analyses with
nti-human IgG. The polypeptide band in Fig. 1B, lane 1,
xerted the calculated molecular mass of the expected
imeric immunoglobulin-like protein including modifica-
cassette. Oligonucleotide primer positions to amplify envSU of SFVcpz
rred into a vector bearing an expression cassette for a human IgG1
8 cells. EnvSU–Ig protein is expressed as a homodimer. (B) Analysis
U–Ig was used for infection of Sf 158 cells (lanes 1 and 2). As controls,
rnatants of infected cells (lanes 1–3) or affinity purified EnvSU–Ig (lane
cing conditions (lane 2). The proteins were detected by immunoblotting
nvSU–Ig after protein A extraction, a representative sample was silverression
transfe
in Sf 15
for EnvS
3). Supe
or redu
vered Eions at up to 12 N-linked glycosylation sites predicted for
S
b
b
E
F
p
G
r
b
o
B
k
a
f
i
S
(
d
i
m
e
m
B
s
c
t
a
n
n
t
B
C
o
i
g
a
l
u
E
i
m
t
c
t
a
d
i
u
b
c
i
C
s
s
t
r
O
c
E
d
p
e
F
t
c
i
C
a
a
c
f
D
o
i
t
F
230 HERCHENRO¨DER ET AL.U. Consequently, disulfide-bond cleavage yielded a
and of roughly half this size (lane 2) while slightly larger
ands may reflect differently glycosylated forms of
nvSU–Ig. In immunoblots, none of several sera from
V-infected chimpanzees reacted with the denatured
olypeptide as reported previously (Netzer et al., 1990;
iron et al., 1993; Hahn et al., 1994). Since native protein
eacts with such sera (see below), the main antibody-
inding epitopes on EnvSU–Ig appear to be discontinu-
us.
inding of EnvSU–Ig to BHK-21 and MT-2 cells
Binding of EnvSU–Ig to FV-permissive baby hamster
idney (BHK-21) and MT-2 cells was studied by FACS
nalysis. To control for binding to BHK-21 cells via the Fc
ragment, two analogous chimeric proteins were tested
n parallel. In place of EnvSU, CD4-Ig (Schlaeger and
chumpp, 1992; Traunecker et al., 1989) and IFNg-Fc
Moosmayer et al., 1994b) contain the two N-terminal
omains of human CD4 or the extracellular portion of the
nterferon-g receptor, respectively. CD4-Ig is produced by
ouse myeloma cells and IFNgR-Fc originates from BV
xpression.
EnvSU–Ig bound to BHK-21 cells in a dose-dependent
anner (Fig. 2A). Binding of CD4-Ig and IFNgR-Fc to
HK-21 cells did not exceed the background control with
econd antibody. Evidently, binding of EnvSU–Ig to the
ell surface is solely mediated by FV SU. Prior trypsiniza-
ion of BHK-21 cells did not alter EnvSU–Ig binding. In
ddition, trypsin treatment 10-fold more excessive than
ecessary for release of BHK-21 from culture dishes did
ot prevent FV infection (data not shown). This indicates
hat the FV receptor is not trypsin sensitive.
Saturation curves for EnvSU–Ig and CD4-Ig binding to
HK-21 cells were compared with those of OKT4a to
D4-positive MT-2 cells. The monoclonal antibody rec-
gnizes the HIV Env binding site and efficiently blocks
nfection and Env-mediated syncytia formation (McDou-
al et al., 1986). The dose–response curves for EnvSU–Ig
nd for OKT4a show a steep increase of binding at low
igand concentrations. In contrast to OKT4a, which sat-
rates MT-2 at about 5 mg/ml, the binding curve for
nvSU–Ig to BHK-21 reaches a shoulder at 5 mg/ml, but
ncreases further without reaching a plateau at up to 50
g/ml. The different slopes observed in the low versus
he high concentration range of the EnvSU–Ig titration
urve are indicative for binding sites with distinct affini-
ies (Fig. 2B). Since control constructs failed to bind even
t highest concentrations, the second slope cannot be
ue to residual binding via Fc.
MT-2 cells assayed with EnvSU–Ig yielded a very sim-
lar dose–response curve. The relative fluorescence val-
es, however, were 20-fold higher than after EnvSU–Ig
inding to BHK-21. This result indicates that the FV re-
eptor expression level in this human lymphoid cell line Ss markedly higher than in the fibroblast-derived BHK-21.
ompared to fibroblasts some lymphoid cell lines con-
istently replicate FVs without marked cytopathology or
yncytia formation (Yu et al., 1996). Our findings indicate
hat these differences may not be explained by low
eceptor expression.
verexpression of FV Env in BHK-21 inversely
orrelates with FV permissiveness and binding of
nvSU–Ig
Expression of viral glycoproteins commonly leads to
own-regulation of the respective virus receptor and
revents superinfection with virus of the same interfer-
nce group (Coffin, 1996). Assuming this mechanism for
V, stable transfectants for FV Env should require higher
iters for FV infection and, inversely, bind less EnvSU–Ig.
FIG. 2. Specific binding of EnvSU–Ig to BHK-21 cells. (A) Binding of
himeric recombinant proteins to BHK-21 cells. 1 3 105 cells were
ncubated with the indicated amounts of EnvSU–Ig (gray columns),
D4-Ig (dotted columns), or IFNgR-Fc (dark columns) and detected with
PE-labeled donkey anti-human Fab fragment. Incubation with second
ntibody only (black column) and determination of nonspecific fluores-
ence of untreated cells (white column) served as controls. The median
luorescence of 10,000 cells was determined by FACS analysis. (B)
ose-dependent binding of soluble ligands to BHK-21 (solid symbols)
r MT-2 cells (open symbols). 1 3 105 cells were incubated with
ncreasing amounts of EnvSU–Ig (squares) or CD4-Ig (circles). To con-
rol for saturation, MT-2 cells were incubated with OKT4a (diamonds).
ACS analyses were done as in A.tably transfected BHK-21 cells expressing high (BHK/
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231BINDING OF FOAMY VIRUS ENVELOPE PROTEIN TO HOST CELLSnv-1) or low levels of Env (BHK/Env-2) were generated
s described under Materials and Methods. Env expres-
ion and fusogenic activity of BHK/Env-1 were visualized
y immunoperoxidase staining and demonstration of
heir potential to fuse with heterologous cells. As illus-
rated in Fig. 3a, panels A and B, all BHK/Env-1 cells
ere stained with an SFVcpz-Env-reactive chimpanzee
erum. In radioimmunoprecipitations (RIPA) with lysates
f [35S]cysteine-labeled BHK/Env-1 and BHK/Env-2 cells
he main polypeptide recognized by this serum had a
olecular mass of about 130 kDa (Fig. 3b, lanes 1 and 2).
his correlates to approximately 1000 aa and 15 glyco-
ylation sites predicted by the DNA sequences (Flu¨gel et
l., 1987) for the HFV Env precursor. Apparently, the
ajority of FV Env precursors remain uncleaved. While
HK/Env-2 did not fuse with naive cells, coincubation of
HK/Env-1 cells with human embryonic lung cells (HEL)
ed to fusion and syncytium formation as after FV infec-
ion. This observation confirmed the presence of suffi-
ient biologically active Env heterodimers at the surface
f BHK/Env-1 to mediate cell fusion (Fig. 3a, panel D). A
arely detectable fraction of the mature SU–TM het-
rodimer may have overcome ER retention to locate at
he cell surface, enabling fusion with receptor-bearing
ells. Had a FV Env precursor lacking the ER retrieval
ignal been overexpressed, one would expect similar
esults by complexation of Env with receptor structures
t the cell surface and further interference with EnvSU–Ig
inding and with syncytia formation by shed Env protein.
Relative permissivity of the different cell lines for FV
as quantitated by counting fluorescent cells following
nfection at a m.o.i. of 1.5 with a recombinant HFV ex-
ressing the green fluorescent protein (GFP; Nestler et
l., 1997). The high conservation between HFV and
FVcpz Env (Herchenro¨der et al., 1994) allowed utiliza-
ion of either one in the assay. As illustrated in Fig. 3c,
inding of EnvSU–Ig positively correlated with suscepti-
ility to FV infection. BHK/Env-1 cells were completely
esistant. Although BHK/Env-2 cells express very small
mounts of Env (Fig. 3b), their susceptibility to infection
as markedly reduced (Fig. 3c). These data support the
ypothesis that Env expression leads to down-regulation
f the receptor, which is demonstrated by both impaired
inding of EnvSU–Ig and lower susceptibility to infection.
nvSU–Ig does not inhibit FV infection
We assumed that EnvSU–Ig blocked FV attachment to
ells and, thereby, prevented infection from without by
eceptor saturation. BHK-21 or BHK/LTRlacZ indicator
ells (1 3 104) were incubated with different amounts of
nvSU–Ig. The cells were then inoculated with wild-type
FVcpz diluted to concentrations yielding either approx-
mately 20 or 200 blue cells when X-gal staining and
yncytia counting were done 40 h p.i. Treatment with
nvSU–Ig did not impair FV permissiveness of either cellype compared with untreated controls. Even cultures
reincubated with 50 mg/ml EnvSU–Ig corresponding to
100-fold excess of the concentration that reached a
houlder in titration curves for the given number of cells
Fig. 2B) did not reduce FV susceptibility. Moreover,
ross-linking of EnvSU–Ig with anti-human IgG had no
nfluence on the results (data not shown).
nhibition of EnvSU–Ig binding by FV neutralizing
himpanzee serum and interference with
eutralization by EnvSU–Ig
The discrepancy between specific binding of EnvSU–Ig
o susceptible cells and its inability to interfere with
nfection could be explained by a too low binding con-
tant that was insufficient to hinder the multivalent virus–
ell interactions. Low affinity of EnvSU–Ig for specific cell
lasma membrane components could for instance result
rom inadequate conformation. Thus, we studied the in-
eraction of EnvSU–Ig with neutralizing chimpanzee se-
um, which presumably inhibits FV attachment by bind-
ng to relevant epitopes of the SU domain. Inhibition of
nvSU–Ig binding by FV neutralizing antibodies should
rove epitope conservation on the chimeric ligand. Vice
ersa, EnvSU–Ig should impair the neutralizing capacity
f the respective serum.
Figure 4A illustrates the influence of two representa-
ive chimpanzee sera on EnvSU–Ig binding to MT-2 cells.
200-fold dilution of neutralizing serum suppressed the
inding of EnvSU–Ig to background levels of serum
lone. A 2000-fold dilution inhibited binding of EnvSU–Ig
o approximately 50% of the control. The slight enhance-
ent of fluorescence seen at the 200-fold dilution of the
onneutralizing serum may reflect binding of chimpan-
ee IgG to MT-2 cells and cross-reactivity with the IgG-
pecific second antibody.
EnvSU–Ig also diminished the inhibiting capacity of
his neutralizing serum (Fig. 4B). In the presence of 1
g/ml EnvSU–Ig the serum requirement for 50% neutral-
zation shifted by a factor of 3.9 from 0.48 to 1.85 ml per
00 ml of culture fluid. Since the neutralizing serum did
ot recognize denatured EnvSU–Ig in Western blots (data
ot shown), the epitopes sensitive for neutralization must
e of the conformational type. Together, these results led
s to conclude that EnvSU–Ig retains the overall confor-
ation with genuine epitopes and, thus, affinities similar
o those of native FV SU protein for the virus receptor(s).
oncluding remarks
This work describes specific interactions between re-
ombinant envelope proteins derived from well-charac-
erized FV isolates and plasma membrane structures of
arget cells. EnvSU–Ig represents a FV surface protein
nalogue that specifically binds to FV susceptible cells
nd may be a useful tool to identify FV receptor proteins.The ultimate proof for specificity of EnvSU–Ig by dem-
232 HERCHENRO¨DER ET AL.
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233BINDING OF FOAMY VIRUS ENVELOPE PROTEIN TO HOST CELLSnstration of interference with FV infection may be hard
o attain for several reasons. Multimeric interactions of
he cell surface with FV particles, which are densely
tudded with club-shaped projections (Gelderblom and
rank, 1987; Yu et al., 1996; Morozov et al., 1997), may
asily displace dimeric EnvSU–Ig. This situation is well
ocumented for the polyomavirus receptor interaction,
here the binding constant of virus (Herrmann et al.,
FIG. 3. Interaction of EnvSU–Ig with Env expressing BHK-21 cells
HK/Env-1 cells (B, D) were either immunoperoxidase stained using FV
ith methylene blue and basic fuchsin (C, D). (b) Demonstration of
35S]cysteine-labeled BHK/Env-1 (lane 1), BHK/Env-2 (lane 2), and BH
reclearing with normal rabbit serum and subsequent SDS–PAGE and
inding capacity and permissiveness toward FV infection in BHK-21
nvSU–Ig. The median fluorescence (gray columns) was determined a
anged from 2.15 in BHK/Env-1 to 3.16 in BHK/Env-2 cells. Susceptibilit
FIG. 4. Neutralization interference of EnvSU–Ig. (A) FV-specific chim-
anzee serum blocks binding of EnvSU–Ig to MT-2 cells. Serially
iluted serum samples from a FV-positive (squares) or an uninfected
himpanzee (diamonds) were preincubated with 1 mg of purified
nvSU–Ig before being applied to MT-2 cells. The extent of EnvSU–Ig
inding was determined as described in the legend to Fig. 2. (B)
nvSU–Ig prevents serum neutralization of FV. Serial dilutions of FV-
pecific chimpanzee serum were either preincubated at 0°C with 1 mg
f EnvSU–Ig for 1 h (diamonds) or left untreated (squares). The mixtures
ere added to aliquots of a pretitrated SFVcpz stock and incubated for
5 min before addition to BHK/LTRlacZ (BHLL) cells. After 3 days the
nfected cells were visualized after X-gal staining..o.i. of 1.5 with recombinant HFV encoding GFP. At 56 h p.i. 10,000 cells we997) exceeds that of a monomeric ligand by seven
rders of magnitude (Stehle et al., 1994). In our system
ell surface-bound EnvSU–Ig can be removed from par-
ially fixed cells by low detergent concentrations (data
ot shown), suggesting weak binding of EnvSU–Ig and,
hus, individual FV SU molecules to the putative receptor.
n contrast, the HIV gp120–CD4 interaction is resistant to
etergent (McDougal et al., 1986; Traunecker et al., 1989).
urthermore, no cell surface protein could be immuno-
recipitated in detergent-dependent assays (data not
hown). The binding curve for EnvSU–Ig to BHK-21 and
T-2 cells exhibited a biphasic shape, and saturation
as not reached at 50 mg/ml of EnvSU–Ig (Fig. 2B). This
s contrasted by the binding curve for OKT4a to MT-2.
he shape of the binding curve for EnvSU–Ig provides
vidence that FV may utilize two receptors with different
ffinities for Env: a primary molecule with higher affinity
nd a much more abundant second receptor with lower
ffinity. HIV, in contrast, initiates infection of highly differ-
ntiated T-helper cells and macrophages by strong and
xclusive binding of gp120 to the conserved CD4 mole-
ule followed by interaction with one of several corecep-
or molecules (Weiss and Clapham, 1996). Though the
trong interaction of HIV gp120 with its receptor has
een studied intensively, only transient interference from
ithout has been reported (Matthews et al., 1987). By
nalogy, the inability of EnvSU–Ig to interfere with FV
nfection does not necessarily contradict its specificity
or binding genuine FV receptor molecules.
The FV entry mechanism may deviate from that of
iruses that express surface proteins with high receptor
ffinities. When speculations are made regarding the
ature of the receptor(s), cell membrane proteins are
ess probable candidates since trypsin did not influence,
ut detergent abrogated, EnvSU–Ig binding. Possibly,
lycosidic residues as part of various membrane pro-
eins or components of the general membrane architec-
ure, e.g., glycolipids, could thus mediate FV attachment.
hese and related molecules are phylogenetically wide-
pread and abundant enough to allow a high density of
nteraction with the virion.
Since FVs replicate in a broad spectrum of target cells
nd tissues, it seems unlikely that FV receptors are
erfectly conserved among all species. Instead, more
olerant mechanisms of docking and entry may have
munoperoxidase staining and cell fusion assays. BHK-21 (A, C) or
e chimpanzee serum (A, B) or cocultivated with HEL cells and stained
nvelope expression in BHK-21 subclones by RIPA. Cell extracts of
ne 3) were precipitated with HFV SU-specific rabbit antiserum after
diography. Lane 4, marker proteins. (c) Correlation between EnvSU–Ig
nv-expressing subclones. 1 3 105 cells were incubated with 4 mg
ribed in the legend to Fig. 2. The average medians without EnvSU–Ig
(black columns) was determined by inoculation of 1 3 105 cells at a. (a) Im
-positiv
HFV-E
K-21 (la
autora
- and E
s desc
y for FV
re assayed for GFP expression by FACS analysis.
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234 HERCHENRO¨DER ET AL.volved with this virus subfamily. Promiscuous receptor
sage is not without precedence in retroviruses (Schnei-
erman et al., 1996; Sommerfelt and Weiss, 1990). This
equirement may be ideally met by weak, yet more ver-
atile, binding of individual envelope spikes to the recep-
or, which is critically enhanced by multiple burr-like
nteractions between the viral and the cellular surfaces.
fficient use of a low-affinity receptor could overcome
hylogenetic variation rather easily and explain the
road in vitro host range of FV.
MATERIALS AND METHODS
onstruction and expression of recombinant proteins
SFVcpz env codes for 988 amino acid (aa) residues
Herchenro¨der et al., 1994). A protease cleavage deter-
ining site at aa 571 after an Arg-Lys-Arg-Arg motif
eparates SU and TM. To construct EnvSU–Ig the infec-
ious proviral clone SFVcpz-B3 (Herchenro¨der et al.,
995) served as template for PCR. The 59 oligonucleotide
rimer (59-GGATCCTACTTCTCATCAGAATGGCAC-39) en-
ompasses the proposed start codon at the proviral nt
154–7156. The reverse primer (59-TCTAGAATTGTTA-
AAGAAGTATAATGTTCTCGG-39) was designed to alter
he protease cleavage site with uncharged aa between
t positions 8855 and 8866. Both primers also contained
estriction sites for BamHI or XbaI (underlined). The
.74-kb envSU amplimer was cloned into pCRII (Invitro-
en). The excised BamHI to XbaI fragment was cloned
n-frame upstream of an expression cassette for the
inge region, CH2, and CH3 of a human IgG1 (Moos-
ayer et al., 1994a) in the baculovirus (BV) transfer vector
VL1393 (Invitrogen; Fig. 1A). This expression vector was
nalogous to IFNgR-Fc bearing the extracellular part of
he interferon-g receptor (Moosmayer et al., 1994b) in
lace of env-SU. IFNgR-Fc and CD4-Ig (Schlaeger and
chumpp, 1992; Traunecker et al., 1989) served as con-
rols in functional assays.
EnvSU–Ig was expressed in a BV system described
reviously (Moosmayer et al., 1994b). Five days postin-
ection of Sf 158 cells with recombinant BV culture, su-
ernatant was harvested. After removal of cellular debris
he recombinant protein was recovered by affinity bind-
ng in the presence of protease inhibitor. One milliliter of
reswollen protein-A–Sepharose (Pharmacia) was
dded to 1 liter supernatant and kept in suspension at
°C overnight. The matrix was then transferred to a
olumn and washed with 20 ml of phosphate-buffered
aline (PBS). EnvSU–Ig was eluted with 50 mM glycine
uffer, pH 2.6, and neutralized with 1 M Tris–Cl, pH 8.5.
wo hundred nanograms per lot of purified protein was
nalyzed by SDS–PAGE and either silver stained or blot-
ed to nitrocellulose membranes and detected with alka-
ine phosphatase-conjugated anti-human IgG (Schneider
t al., 1996). iells and virus isolates
Adherent mammalian cells were grown in Dulbecco’s
odified Eagle’s medium (DMEM) and HTLV-I trans-
ormed human lymphoid MT-2 cells in RPMI 1640. Both
edia were supplemented with 10% FCS and antibiotics.
f 158 cells were grown as monolayers at 27°C in TC100
edium (Life Technologies) supplemented with 10%
CS.
Most experiments were carried out with BHK-21 cells
nd subclones thereof. BHK/Env-1 cells were selected
rom HFV env transfected cells that had resisted lysis
ue to the fusogenic activity of Env (Moebes et al., 1997).
o generate BHK/Env-2 cells a 3.49-kb EcoRI fragment of
HSRV1 (Rethwilm et al., 1990) encompassing the HFV
nv gene was inserted into the EcoRI site of the retroviral
ector pLEN (Adam and Miller, 1991). BHK-21 cells were
ransfected with the resultant plasmid, selected in 1.0
g/ml G418, and screened for Env expression by indirect
mmunofluorescence with a rabbit anti-HFV SU serum
Lehrmann et al., 1998). BHK/Env-2 were recovered after
wo rounds of limiting dilution.
Staining with methylene blue and basic fuchsin or with
mmunoperoxidase after reaction with FV-positive chim-
anzee serum on human embryonic lung or BHK-21 cells
as done according to standard procedures. BHK/
TRlacZ indicator cells were used as described (Schmidt
nd Rethwilm, 1995).
SFVcpz was propagated in BHK-21 or Cf2Th canine
ibroblast cells (Herchenro¨der et al., 1994). Supernatants
ere filtered through 0.45-mm-pore-size nitrocellulose
embranes and titrated on BHK/LTRlacZ indicator cells
Herchenro¨der et al., 1995). Alternatively, infection by
ecombinant HFV encoding GFP (FOV-7/gfp; Nestler et
l., 1997) was visualized by fluorescence microscopy and
ounting of lucent cells.
inding studies with EnvSU–Ig by flow cytometry
Adherent cells were treated with PBS/EDTA or trypsin
nd washed while MT-2 cells were directly sedimented.
ll subsequent procedures were done at 0°C. Cells (1 3
05) were resuspended in 350 ml medium with the indi-
ated ligands and incubated for 1 h. The cells were
ashed with 4 ml of PBS and treated with 1 mg of a
hycoerythrin-labeled donkey anti-human Fab fragment
Dianova). After being washed, the cells were suspended
n 0.2% paraformaldehyde in PBS and analyzed in a
ACSSort (Becton Dickinson) using CELLQuest software.
n a set of blocking experiments with the mouse mono-
lonal antibody OKT4a, EnvSU–Ig was preincubated with
erum 1 h before addition to the cells.
rotein detection methods
Env expression was detected by RIPA, immunoperox-
dase labeling, or indirect immunofluorescence with a
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235BINDING OF FOAMY VIRUS ENVELOPE PROTEIN TO HOST CELLSV-positive chimpanzee serum (Ro¨sener et al., 1996) or a
abbit anti-HFV-Env serum and applying methods de-
cribed previously (Schneider et al., 1984; Bieniasz et al.,
995; Lindemann and Rethwilm, 1998).
irus neutralization assay
The infectivity of serial virus dilutions was determined
n BHK/LTRlacZ indicator cells. Cells (1 3 104) were
noculated with pretitrated SFVcpz stocks. To examine
nterference with virus attachment, EnvSU–Ig was added
t concentrations between 1 and 50 mg/ml 2 h prior to
noculation. To test the influence of EnvSU–Ig on virus
eutralization of a FV-positive chimpanzee serum, both
omponents were mixed at different ratios and incubated
or 1 h prior to addition to the cells.
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